These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36749458)

  • 1. Validation of a breast cancer risk prediction model based on the key risk factors: family history, mammographic density and polygenic risk.
    Allman R; Mu Y; Dite GS; Spaeth E; Hopper JL; Rosner BA
    Breast Cancer Res Treat; 2023 Apr; 198(2):335-347. PubMed ID: 36749458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study.
    Zhang X; Rice M; Tworoger SS; Rosner BA; Eliassen AH; Tamimi RM; Joshi AD; Lindstrom S; Qian J; Colditz GA; Willett WC; Kraft P; Hankinson SE
    PLoS Med; 2018 Sep; 15(9):e1002644. PubMed ID: 30180161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practical problems with clinical guidelines for breast cancer prevention based on remaining lifetime risk.
    Quante AS; Whittemore AS; Shriver T; Hopper JL; Strauch K; Terry MB
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25956172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort.
    Brentnall AR; Harkness EF; Astley SM; Donnelly LS; Stavrinos P; Sampson S; Fox L; Sergeant JC; Harvie MN; Wilson M; Beetles U; Gadde S; Lim Y; Jain A; Bundred S; Barr N; Reece V; Howell A; Cuzick J; Evans DG
    Breast Cancer Res; 2015 Dec; 17(1):147. PubMed ID: 26627479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance.
    Quante AS; Whittemore AS; Shriver T; Strauch K; Terry MB
    Breast Cancer Res; 2012 Nov; 14(6):R144. PubMed ID: 23127309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 10-year performance of four models of breast cancer risk: a validation study.
    Terry MB; Liao Y; Whittemore AS; Leoce N; Buchsbaum R; Zeinomar N; Dite GS; Chung WK; Knight JA; Southey MC; Milne RL; Goldgar D; Giles GG; McLachlan SA; Friedlander ML; Weideman PC; Glendon G; Nesci S; Andrulis IL; John EM; Phillips KA; Daly MB; Buys SS; Hopper JL; MacInnis RJ
    Lancet Oncol; 2019 Apr; 20(4):504-517. PubMed ID: 30799262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simplified Breast Risk Tool Integrating Questionnaire Risk Factors, Mammographic Density, and Polygenic Risk Score: Development and Validation.
    Rosner B; Tamimi RM; Kraft P; Gao C; Mu Y; Scott C; Winham SJ; Vachon CM; Colditz GA
    Cancer Epidemiol Biomarkers Prev; 2021 Apr; 30(4):600-607. PubMed ID: 33277321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing breast cancer risk models in Marin County, a population with high rates of delayed childbirth.
    Powell M; Jamshidian F; Cheyne K; Nititham J; Prebil LA; Ereman R
    Clin Breast Cancer; 2014 Jun; 14(3):212-220.e1. PubMed ID: 24461459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammographic density correlation with Gail model breast cancer risk estimates and component risk factors.
    Palomares MR; Machia JR; Lehman CD; Daling JR; McTiernan A
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1324-30. PubMed ID: 16835331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information.
    Mealiffe ME; Stokowski RP; Rhees BK; Prentice RL; Pettinger M; Hinds DA
    J Natl Cancer Inst; 2010 Nov; 102(21):1618-27. PubMed ID: 20956782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer risk prediction in women aged 35-50 years: impact of including sex hormone concentrations in the Gail model.
    Clendenen TV; Ge W; Koenig KL; Afanasyeva Y; Agnoli C; Brinton LA; Darvishian F; Dorgan JF; Eliassen AH; Falk RT; Hallmans G; Hankinson SE; Hoffman-Bolton J; Key TJ; Krogh V; Nichols HB; Sandler DP; Schoemaker MJ; Sluss PM; Sund M; Swerdlow AJ; Visvanathan K; Zeleniuch-Jacquotte A; Liu M
    Breast Cancer Res; 2019 Mar; 21(1):42. PubMed ID: 30890167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of Rosner-Colditz breast cancer incidence model using an independent data set, the California Teachers Study.
    Rosner BA; Colditz GA; Hankinson SE; Sullivan-Halley J; Lacey JV; Bernstein L
    Breast Cancer Res Treat; 2013 Nov; 142(1):187-202. PubMed ID: 24158759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population.
    Tice JA; Cummings SR; Ziv E; Kerlikowske K
    Breast Cancer Res Treat; 2005 Nov; 94(2):115-22. PubMed ID: 16261410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of Breast Cancer Risk-Assessment Models in a Large Mammography Cohort.
    McCarthy AM; Guan Z; Welch M; Griffin ME; Sippo DA; Deng Z; Coopey SB; Acar A; Semine A; Parmigiani G; Braun D; Hughes KS
    J Natl Cancer Inst; 2020 May; 112(5):489-497. PubMed ID: 31556450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inclusion of Endogenous Plasma Dehydroepiandrosterone Sulfate and Mammographic Density in Risk Prediction Models for Breast Cancer.
    Gabrielson M; Ubhayasekera KA; Acharya SR; Franko MA; Eriksson M; Bergquist J; Czene K; Hall P
    Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):574-581. PubMed ID: 31948996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
    J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective validation of the NCI Breast Cancer Risk Assessment Tool (Gail Model) on 40,000 Australian women.
    Nickson C; Procopio P; Velentzis LS; Carr S; Devereux L; Mann GB; James P; Lee G; Wellard C; Campbell I
    Breast Cancer Res; 2018 Dec; 20(1):155. PubMed ID: 30572910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing breast cancer risk within the general screening population: developing a breast cancer risk model to identify higher risk women at mammographic screening.
    Abdolell M; Payne JI; Caines J; Tsuruda K; Barnes PJ; Talbot PJ; Tong O; Brown P; Rivers-Bowerman M; Iles S
    Eur Radiol; 2020 Oct; 30(10):5417-5426. PubMed ID: 32358648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammographic Breast Density and Common Genetic Variants in Breast Cancer Risk Prediction.
    Lee CP; Choi H; Soo KC; Tan MH; Chay WY; Chia KS; Liu J; Li J; Hartman M
    PLoS One; 2015; 10(9):e0136650. PubMed ID: 26401662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of changing breast cancer incidence rates on the calibration of the Gail model.
    Schonfeld SJ; Pee D; Greenlee RT; Hartge P; Lacey JV; Park Y; Schatzkin A; Visvanathan K; Pfeiffer RM
    J Clin Oncol; 2010 May; 28(14):2411-7. PubMed ID: 20368565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.